Literature DB >> 25227773

Neuroarthropathy of the foot revealing primary systemic amyloidosis: case report and literature review.

Irina Adriana Andrei1, Thierry Kuntzer2, Johannes Alexander Lobrinus3, Arnaud Jaccard4, Pascal Zufferey5.   

Abstract

The aims of this review were to describe the case of a patient with debilitating neuroarthropathy of the ankles and feet and reveal a primary systemic (amyloid light chain, AL) amyloidosis and to review the relevant literature concerning the peripheral neuropathy and neuroarthropathy due to amyloidosis. We will emphasize the diagnostic pitfalls and discuss prognosis and treatments of both the peripheral neuropathy and the arthropathy related to AL amyloidosis. This is a descriptive case report of a patient with neuroarthropathy of the lower limbs due to AL amyloidosis. A review and discussion of relevant literature were conducted, based on a PubMed search from 1973 to December 2013. A 51-year-old female was diagnosed with AL amyloidosis after 20 months of investigation of small painful deformities of the feet. Chronic peripheral neuropathy occurs as a manifestation of AL amyloidosis in 25 % of cases. It may exceptionally be complicated by neuroarthropathy. In this case, the paucity of clinical and electrophysiological signs of the neuropathy delayed the diagnosis, leading to a severe arthropathy. The massive destruction of the joints dominated the clinical and the poor functional outcome. Diagnosis of AL amyloidosis should be considered in the presence of a mild peripheral neuropathy and a distal destructive and painless arthropathy. The two key diagnostic procedures are serum protein electrophoresis and nerve biopsy. Delay in treatment worsens the prognosis.

Entities:  

Keywords:  Amylosis; Charcot arthropathy; Diabetic foot; MRI; Nerve biopsy; Neuroarthropathy

Mesh:

Year:  2014        PMID: 25227773     DOI: 10.1007/s10067-014-2782-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.

Authors:  S V Rajkumar; M A Gertz; R A Kyle
Journal:  Am J Med       Date:  1998-03       Impact factor: 4.965

2.  Charcot arthropathy secondary to amyloid neuropathy.

Authors:  S J Peitzman; J L Miller; L Ortega; H R Schumacher; P C Fernandez
Journal:  JAMA       Date:  1976-03-29       Impact factor: 56.272

Review 3.  Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature.

Authors:  J-L Richard; M Almasri; S Schuldiner
Journal:  Diabetologia       Date:  2012-02-25       Impact factor: 10.122

4.  Synovial fluid analysis for diagnosis of amyloid arthropathy.

Authors:  S Lakhanpal; C Y Li; M A Gertz; R A Kyle; G G Hunder
Journal:  Arthritis Rheum       Date:  1987-04

5.  Skin lesions of the legs and feet and skeletal lesions of the feet in familail amyloidosis with polyneuropathy.

Authors:  F Lithner
Journal:  Acta Med Scand       Date:  1976

Review 6.  Primary systemic amyloidosis--a diagnostic primer.

Authors:  M A Gertz; R A Kyle
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

Review 7.  Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2013-05       Impact factor: 10.047

Review 8.  Charcot arthropathy of the foot and ankle: modern concepts and management review.

Authors:  Dane K Wukich; Wenjay Sung
Journal:  J Diabetes Complications       Date:  2008-10-17       Impact factor: 2.852

9.  Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy.

Authors:  W Pruzanski; M Baron; R Shupak
Journal:  J Rheumatol       Date:  1981 May-Jun       Impact factor: 4.666

Review 10.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.